CXCL5 and hepatocellular carcinoma: The role of CXCL5 in recruiting CXCR2+ MDSC and TAN has also been shown in models of renal cell carcinoma (RCC) (17), PDA (18), melanoma (19, 20), and hepatocellular carcinoma (HCC) (21).